Ginsenoside Rg1 modulates intestinal microbiota and supports re-generation of immune cells in dexamethasone-treated mice
Acta Microbiologica et Immunologica Hungarica · 06.12.2022 · 69 (4) · 259-269
DOI: 10.1556/030.2022.01881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, erschienen am 06.12.2022. Verfasst von Sabiha Yousuf und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1College of Basic Medical Sciences, Dalian Medical University, 9-Western Section, Lvshun South Road, Dalian, Liaoning, 116044, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning Provincial Program for Top Discipline of Basic Medical Sciences.
Abstract (Originalsprache)
Ginsenoside Rg1 is one of the major ginsenosides found in roots of Panax ginseng and Panax notoginseng . Ginsenoside Rg1 is known to possess various biological activities including immunity enhancement activity. However, it is not clear whether the regulation of immune function by Rg1 is related to the intestinal microbiota. In the present study, the immuno-modulatory and gut microbiota-reshaping effects of ginsenoside Rg1 were evaluated. Ginsenoside Rg1 acts as an immune-enhancing agent to increase spleen index and the number of T, B and dendritic cells in dexamethasone (Dex)-treated mice. Ginsenoside Rg1 also increased the production of sIgA and regulated the expression of interleukin 2 (IL-2), IL-4, IL-10 and IFN-γ. Meanwhile, Rg1 administration regulated the structure of intestinal microbiota. The relative abundance of mouse intestinal microbial groups, such as Alistipes, Ruminococcaceae, Lachnospiraceae, and Roseburia were increased by Rg1 administration, whereas a decrease in the potential pathogens like Helicobacteraceae, Dubosiella, Mycoplasma, Alloprevotella, Allobaculum was observed. Moreover, Rg1 metabolites of Lachnospiraceae bacterium enhanced the proliferation of CD4 + T cells and T regulatory (Treg) cells. Ginsenoside Rg1 improved the inflammatory condition of the colonic tissue and repaired the destructed mucosal barrier. This study suggested that Rg1 strengthens immunity with regulating the homeostasis of intestinal microbiota in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1College of Basic Medical Sciences, Dalian Medical University, 9-Western Section, Lvshun South Road, Dalian, Liaoning, 116044, China.
- 2Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, 116044, China.
- 3School of Food Science and Technology, Dalian Polytechnic University, Dalian, Liaoning, 116034, China.
- 4Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Shantou University Medical College, Shantou, Guangdong, 515041, China.
Förderung
- National Natural Science Foundation of China
- Liaoning Provincial Program for Top Discipline of Basic Medical Sciences
Zitieren
APA
Yousuf, S., Liu, H., Yingshu, Z., Zahid, D., Ghayas, H., Li, M., Ding, Y., & Li, W. (2022). Ginsenoside Rg1 modulates intestinal microbiota and supports re-generation of immune cells in dexamethasone-treated mice. Acta Microbiologica et Immunologica Hungarica, 69(4), 259-269. https://doi.org/10.1556/030.2022.01881
Vancouver
Yousuf S, Liu H, Yingshu Z, Zahid D, Ghayas H, Li M, et al. Ginsenoside Rg1 modulates intestinal microbiota and supports re-generation of immune cells in dexamethasone-treated mice. Acta Microbiologica et Immunologica Hungarica. 2022;69(4):259-269. doi:10.1556/030.2022.01881
BibTeX
@article{Yousuf2022,
author = {Yousuf, Sabiha and Liu, He and Yingshu, Zhang and Zahid, Danish and Ghayas, Hassan and Li, Ming and Ding, Yan and Li, Wenzhe},
title = {Ginsenoside Rg1 modulates intestinal microbiota and supports re-generation of immune cells in dexamethasone-treated mice},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2022},
volume = {69},
number = {4},
pages = {259--269},
doi = {10.1556/030.2022.01881}
}
EUVIMED